RNAC Gross Profit Growth
Cartesian Therapeutics Inc · Gross Profit Growth
RNAC Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported-1203.31%period ending
RNAC TTM Gross Profit YoY % (34.47% → -1203.31%)
Year-over-year change
High-resolution chart · PNG
RNAC gross profit growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Gross Profit Growth |
|---|---|
| -1,203.3138% | |
| -132.2535% | |
| -125.6984% | |
| -124.419% | |
| -97.5036% | |
| 800.5535% | |
| 266.2665% | |
| 409.637% | |
| 268.9408% | |
| -107.8113% | |
| -121.5727% | |
| -112.6655% | |
| -91.1933% | |
| -41.845% | |
| 27.5186% | |
| 82.1973% | |
| 167.3726% | |
| 288.4038% | |
| 412.6047% | |
| 493.7257% | |
| 611.0009% | |
| 314.6843% | |
| 148.5697% | |
| 1,120.3024% | |
| 618.5745% | |
| 630.23% | |
| 639.4241% | |
| 5,347.0588% | |
| 2,004.5455% | |
| 1,204.2857% | |
| 336.2319% | |
| -99.4551% | |
| -98.9375% | |
| -98.8584% | |
| -97.4391% | |
| -57.184% | |
| -47.2215% | |
| -13.2059% | |
| 34.4701% |